BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


July Archive 2004 - have your press release here?

DNA Research Innovations launches GeneCatcher

AnalytiCon Discovery: Discovery and Development of New Classes of Anti-Cancer-Drugs

Grant BTD - round, rapid, reliable heating

HomelandDefenseStocks.com Reports on The Security Implications of AIDS

GM planting regime: report of the Environment, Food & Rural Affairs Committee ignores important evidence submitted to it 

PROLYSIS ANNOUNCES APPOINTMENT OF PROFESSOR ROGER FINCH TO SCIENTIFIC ADVISORY BOARD

QualityMetric announces royalty-free access to DYNHA® for scholarly research

Peakdale launches 2nd GPCR targeted library ahead of plan

Pharmaceutical companies set to make a significant profit from anti-obesity drugs

Agilent Technologies Introduces Qualification Service for GCs' Heated Zones

Roche's Fuzeon offers hope...to the 20% of patients that receive it

Agilent Technologies Gains Exclusive Rights to Sell SSI's CyberLAB Enterprise Content Management System 

What’s new at BIOPHEX2004?

Life Sciences Day of DVC Deutsche Venture Capital – Highlights and Trends in the Biotechnology-Sector in Germany

New Automated System for Microscopes Offers High-speed Slide Scanning to Create Precise Image Maps

AnalytiCon Discovery: Successful collaboration with Kyowa Hakko

Vernalis plc and Endo Pharmaceuticals Holdings Inc. Announce North American Licence Agreement and Co-Promotion Option for Frova™

BioPortfolio Bulletin - Bioterrorism, Anthrax, Smaalpox, Vaccines, New Reports

Scancell Company Profile

OneWorld Health to Work with Sanaria Inc. on Novel Malaria Vaccine Approach 

Advances in the development of corticotropin-releasing-hormone (CRH) receptor agonists as candidate analgesics

Agilent Technologies Introduces Proteomics Product to Remove High-Abundance Proteins from Mouse Blood Serum 

Prolysis Company Profile

No recovery in Pharmaceutical Fine Chemicals market until 2005

DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd.

Morphochem appoints Sijmen de Vries as CEO

The emerging role of the IL-4/IL-3 cytokine receptor IL-4Ralpha in asthma

Haptogen granted European patent for it’s DBDx™ display technology

Strong potential for cross risk-factor single pill therapies

PHARMACEUTICAL COMPANIES SET TO MAKE A SIGNIFICANT PROFIT from OBESITY

Tissue Microarrays : Market Assessment and Opportunities

RNAi the hottest technology in drug discovery

Proteomics market shows rapid growth

Eden Biopharma Group raises £5million in investment

André Pernet joins Bionest Partners as associate member

National Biomanufacturing Centre paves the way for European Biotech Success

BioPortfolio Bulletin - Life Science directories, Protein Crystallography, Directory of Molecular Diversity Suppliers, Tissue Microarrays

Avidis names new CEO and management committee members

OXFORD BIOMEDICA LICENSES LENTIVECTOR TECHNOLOGY TO VIRAGEN FOR AVIAN TRANSGENICS BIOMANUFACTURING

atugen and Eisai Sign First Contract Research Agreement

Early adopters of ePrescribing serve as models in a growing market

METABOLIC SYNDROME REACHES EPIDEMIC LEVEL

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.